Cataract

 

 

 

 

 

 

 

Crystalens® intraocular lens (IOL)

Crystalens® intraocular lens (IOL), the first and only U.S. Food and Drug Administration-approved accommodating IOL for the treatment of cataracts, joins Bausch & Lomb’s portfolio of innovative ophthalmic surgical products for cataract, vitreoretinal and refractive markets.  

See what your patients are seeing

Visit crystalens.com to see what your patients are seeing.